These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7335622

  • 1. [Prolonged QT interval and "torsades de pointes" after therapy with prenylamin (Segontin) (author's transl)].
    Burri C, Ajdacic K, Michot F.
    Schweiz Rundsch Med Prax; 1981 Apr 14; 70(16):717-20. PubMed ID: 7335622
    [No Abstract] [Full Text] [Related]

  • 2. [A case of prenylamine syncope (torsades de pointes)].
    Oda E, Takeda K, Ohno T, Nagai T, Shibuya T, Aizawa Y, Arai Y, Ozawa T, Shibata A.
    Kokyu To Junkan; 1985 Mar 14; 33(3):453-8. PubMed ID: 4012076
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Possible female preponderance in prenylamine-induced 'torsade de pointes' tachycardia. Short communication.
    Abinader EG, Shahar J.
    Cardiology; 1983 Mar 14; 70(1):37-40. PubMed ID: 6850685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prolonged Q-T interval, syncope and prenylamine].
    Fazzini PF, Marchi F, Pucci P.
    G Ital Cardiol; 1973 Mar 14; 3(2):233-9. PubMed ID: 4123358
    [No Abstract] [Full Text] [Related]

  • 7. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C, Várkonyi T, Fazekas T.
    Orv Hetil; 1997 Apr 20; 138(16):1003-6. PubMed ID: 9153994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Torsade de pointes due to prenylamine controlled by lignocaine.
    Tamari I, Rabinowitz B, Neufeld HN.
    Eur Heart J; 1982 Aug 20; 3(4):389-92. PubMed ID: 7128627
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S, Marte F, Di Bella G, Currò A, Coglitore S.
    Int J Cardiol; 2008 Nov 12; 130(2):e71-3. PubMed ID: 18255176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
    Kawabata M, Hirao K, Takeshi S, Sakurai K, Inagaki H, Hachiya H, Isobe M.
    J Electrocardiol; 2008 Nov 12; 41(2):117-22. PubMed ID: 18328336
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Torsade de pointes: the clinical considerations.
    Gowda RM, Khan IA, Wilbur SL, Vasavada BC, Sacchi TJ.
    Int J Cardiol; 2004 Jul 12; 96(1):1-6. PubMed ID: 15203254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.